Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Cash (2016 - 2025)

Veracyte (VCYT) has disclosed Change in Cash for 14 consecutive years, with $47.7 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 238.22% to $47.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $123.6 million through Dec 2025, up 430.43% year-over-year, with the annual reading at $123.6 million for FY2025, 430.43% up from the prior year.
  • Change in Cash hit $47.7 million in Q4 2025 for Veracyte, down from $95.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $95.4 million in Q3 2025 to a low of -$161.8 million in Q3 2021.
  • Historically, Change in Cash has averaged $712950.0 across 5 years, with a median of $9.4 million in 2021.
  • Biggest five-year swings in Change in Cash: soared 346.22% in 2023 and later crashed 661.51% in 2025.
  • Year by year, Change in Cash stood at $7.5 million in 2021, then plummeted by 311.82% to -$15.9 million in 2022, then skyrocketed by 188.23% to $14.0 million in 2023, then tumbled by 346.68% to -$34.5 million in 2024, then soared by 238.22% to $47.7 million in 2025.
  • Business Quant data shows Change in Cash for VCYT at $47.7 million in Q4 2025, $95.4 million in Q3 2025, and $33.5 million in Q2 2025.